RTX and Northrop Grumman conduct successful rocket motor tests for U.S. Army's Next-Generation Short-Range Interceptor | Raytheon advances NGSRI development with continued testing
TUCSON, Ariz., June 5, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, and Northrop Grumman... ► Artikel lesen |
Dividendenbekanntmachungen (02.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCOR SA FR0000120404 - 1,26 EUR ASSOCIATED BANC-CORP US0454871056 0,23 USD 0,2026 EUR ATOUR LIFESTYLE HOLDINGS LTD ADR US04965M1062 0... ► Artikel lesen |
Northrop Grumman Invests $50Mln In Firefly's Eclipse Rocket Program | WASHINGTON (dpa-AFX) - Northrop Grumman Corp. (NOC), Thursday announced that it has committed $50 million to Firefly Aerospace to accelerate production of their jointly developed medium class... ► Artikel lesen |
Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering | Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the pricing of an underwritten offering consisting of 12,235,000 shares of its common stock and pre-funded warrants... ► Artikel lesen |
Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease | All dosed patients have passed one-year milestone required by U.S. Food and Drug Administration (FDA) for Accelerated Approval regulatory pathway for ST-920. According to preliminary analysis... ► Artikel lesen |
Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) | One abstract accepted as platform presentation in prestigious Presidential Symposium, demonstrating potent combination of epigenetic regulation and capsid delivery technology in treating prion... ► Artikel lesen |